TFGT
OGEN icon

TS Financial Group (TSFG)’s Oragenics OGEN Stock Holding History

TS Financial Group (TSFG)’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2
Closed -$1K – 1007
2022
Q3 		$1K Hold
2
– – ﹤0.01% 906
2022
Q2 		$1K Hold
2
– – ﹤0.01% 927
2022
Q1 		$1K Hold
2
– – ﹤0.01% 873
2021
Q4 		$1K Hold
2
– – ﹤0.01% 840
2021
Q3 		$2K Hold
2
– – ﹤0.01% 759
2021
Q2 		$2K Hold
2
– – ﹤0.01% 753
2021
Q1 		$3K Sell
2
-1
-33% -$1.82K ﹤0.01% 644
2020
Q4 		$2K Hold
3
– – ﹤0.01% 748
2020
Q3 		$3K Hold
3
– – ﹤0.01% 608
2020
Q2 		$3K Hold
3
– – ﹤0.01% 594
2020
Q1 		$3K Buy
+3
New +$2.88K ﹤0.01% 552

Other funds holding OGEN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SBF
Sara-Bay Financial Sarasota, Florida $375M AUM 56.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

TS Financial Group (TSFG)'s OGEN Position: Q4 2022 in Review

TS Financial Group (TSFG) sold out of Oragenics (OGEN) in Q4 2022, closing a stake of 2 shares — an estimated $1K sold.

TS Financial Group (TSFG) first reported a position in OGEN in Q1 2020 and held it in 11 quarters. The position peaked at $3K in Q1 2021. 24 funds tracked by Wall St. Rank hold OGEN as of Q4 2022.

  • TS Financial Group (TSFG) reported no remaining Oragenics position as of Q4 2022 after selling out during the quarter.
  • TS Financial Group (TSFG) sold 2 Oragenics shares in Q4 2022, an estimated $1K.
  • TS Financial Group (TSFG) first reported a position in Oragenics in Q1 2020 and held it in 11 quarters.
  • TS Financial Group (TSFG)'s Oragenics position peaked at $3K in Q1 2021.
  • 24 funds tracked by Wall St. Rank held Oragenics as of Q4 2022.

Based on TS Financial Group (TSFG)'s 13F filing for Q4 2022, filed 19 Jan 2023.